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Wnt and Neuregulin1/ErbB signalling extends
3D culture of hormone responsive mammary
organoids
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The development of in vitro culture systems quantitatively and qualitatively recapitulating
normal breast biology is key to the understanding of mammary gland biology. Current
three-dimensional mammary culture systems have not demonstrated concurrent proliferation
and functional differentiation ex vivo in any system for longer than 2 weeks. Here, we identify
conditions including Neuregulin1 and R-spondin 1, allowing maintenance and expansion of
mammary organoids for 2.5 months in culture. The organoids comprise distinct basal and
luminal compartments complete with functional steroid receptors and stem/progenitor cells
able to reconstitute a complete mammary gland in vivo. Alternative conditions are also
described that promote enrichment of basal cells organized into multiple layers surrounding a
keratinous core, reminiscent of structures observed in MMTV-Wnt1 tumours. These
conditions comprise a unique tool that should further understanding of normal mammary
gland development, the molecular mechanism of hormone action and signalling events whose
deregulation leads to breast tumourigenesis.
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A
detailed knowledge of normal mammary gland develop-
ment and the mechanisms driving its molecular, cellular
and hormonal regulation, is fundamental to an under-
standing of the initiation and progression of breast cancer. The
mammary gland consists of an elaborate, tree-like network of
branched ducts and lobular alveolar structures, embedded within
a stromal fat pad. Bilayered ductal and alveolar structures possess
an inner layer of luminal epithelial cells surrounding a central
lumen, and an outer layer of basal cells, enveloped by a laminin-
rich basement membrane separating the parenchymal and
stromal compartments. The luminal cell layer is composed of
two functionally distinct lineages deﬁned by the expression or
absence of steroid hormone receptors. The basal cell population
consists of myoepithelial cells with contractile properties and
presumptive multipotent mammary stem cells, although distinct
unipotent stem cells committed to either luminal or basal lineages
have also been reported1,2.
The development of three-dimensional (3D) mammary
gland in vitro culture systems has contributed greatly to the
understanding of mammary gland biology, offering insights into
cell–cell interactions, paracrine signalling, cell proliferation,
differentiation and hormonal regulation3–5. Furthermore,
research into the stem cell niche and breast carcinogenesis has
been facilitated by the ability to culture complex multicellular
mammary structures in 3D. Thus far, however, studies have
yet to establish culture conditions concurrently enabling
sustained proliferation, stem cell maintenance and functional
differentiation in tissues ex vivo for extended periods. For
example, a recent strategy combining Wnt-3a-mediated Wnt
signalling activation and epidermal growth factor (EGF)
treatment allows long-term expansion of murine mammary
stem cells able to form small, disorganized round colonies in 3D
culture6. In contrast, a cocktail of biological factors including
insulin, EGF or ﬁbroblast growth factor allow the short-term
maintenance of polarized epithelial cells surrounding a lumen
that contains distinct basal and luminal cell compartments in
which cells express steroid receptors5,7–10. In this case, the outer
basal layer possesses a discontinuous cellular structure, while the
expression of steroid receptors and cell proliferation are strongly
decreased, with organoids maintained at most for 14–21 days in
culture5,8–12.
In an effort to extend the time over which stem cell activity,
functional differentiation and cellular organization can be
concurrently maintained within mammary organoids, we identify
novel culture conditions, including Neuregulin1 (Nrg1) and low
concentrations of R-spondin 1. Importantly, luminal cells retain
functional steroid hormone receptor-positive and -negative cells,
while basal cells contain functional stem/progenitor cells and
differentiated myoepithelial cells, for 2.5 months in culture.
We conﬁrm the role of Wnt signalling in driving organoid
growth using small molecule Wnt inhibitors and a Tet-O-DN89
b-catenin transgenic system. Similarly, lentiviral knockdown of
Nrg1 receptors validates the important role of Nrg1 signalling in
mammary organoid development. Interestingly, cells capable of
forming mammary organoids containing each cell type are
identiﬁed within the luminal oestrogen receptor (ER)-negative
cell population.
Results
Nrg1 mediated extended growth of mammary organoids.
3D culture conditions that allow the long-term maintenance of
several epithelial tissues in vitro, including intestine, stomach,
liver and prostate, have been recently deﬁned13–16. Here, the basal
culture medium (DMEM/F-12 supplemented with penicillin/
streptomycin, 10mM HEPES, Glutamax, 1 N2, 1 B27)
described in these papers was adapted to include progesterone-
free B27 and N2 reagents based on the original formulation from
Brewer et al.17 and Chen et al.18 (Supplementary Tables 1 and 2).
One of the key constituents of the culture medium enabling
the growth of organoids from gastrointestinal and prostate
tissues was EGF13–16. Although EGF has been used for decades
in multiple mammary gland culture systems19, long-term
maintenance of both proliferation and functional differentiation
of mammary cells ex vivo using this factor has not been possible.
In an attempt to overcome this limitation, we explored the
function of another member of the EGF family of ligands, Nrg1.
Nrg1 contains an EGF-like domain that signals by stimulating
ErbB receptor tyrosine kinases (ErbB3 and ErbB4) (ref. 20),
and is known to regulate different aspects of mammary gland
development21–23. Mammary epithelial organoids were isolated24
and embedded in growth-factor reduced matrigel, a mouse
tumour-derived matrix that allows the development of complex
3D structures13. Following matrigel polymerization, basal culture
medium supplemented with Nrg1 (100 ngml 1) and Noggin
(100 ngml 1) was overlaid.
Compared with cultures treated with EGF (100 ngml 1)
and Noggin (100 ngml 1), Nrg1-treated organoids after
15 days exhibited over a threefold increase in cell viability
(Supplementary Fig. 1a), and appeared larger in size
(Supplementary Fig. 1b), indicating this ligand to be important
in promoting mammary development. By 30 days in culture,
these conditions had enabled the growth of complex lobular
mammary structures possessing multiple lumens per lobule
(Fig. 1a). Organoids were arranged into two distinct cell
compartments: an outer layer of cells expressing basal markers
including keratin-14 (K14), p63 and smooth muscle actin (SMA),
and an inner cell population expressing luminal markers such as
keratin-8 (K8), progesterone receptor (PR) and ER (Fig. 1a and
Supplementary Fig. 2). Whilst the large majority of basal-like cells
co-expressed K14, p63 and SMA, a few basally located,
p63-positive cells per structure did not express SMA
(Supplementary Fig. 2, white arrows). Mammary cells within
the luminal compartment co-expressed ER and PR (Fig. 1b).
When cells from Axin2-lacZ knock-in reporter mice were
analysed, occasional LacZ-positive cells were observed within
the basal cell layers adjoining the matrix, while b-catenin protein
was predominantly localized at cell junctions (Fig. 1a and
Supplementary Fig. 3a). Interestingly, both basal and luminal
cells expressed Na-K-Cl cotransporter 1 (NKCC1), a marker
particularly associated with ductal, rather than alveolar,
morphology25.
Both basal and luminal cells within the organoids were actively
cycling based on Ki-67 staining and on the nuclear incorporation
of BrdU that had been added 2.5 h before ﬁxation (Fig. 1a).
A Nrg1 titration demonstrated that organoid viability and growth
were strongly dependent on the addition of Nrg1, reﬂected by the
number and size of organoids formed (Fig. 1c and Supplementary
Fig. 4). The speciﬁcity of the antibodies used in this study was
validated on mammary gland tissue sections (Supplementary
Fig. 5), and mouse and rabbit IgG isotype antibodies used as
controls (Supplementary Fig. 6).
To demonstrate the maintenance of regenerative potential of
these organoids in vivo after 30 days in culture, 50 mammary
structures were transplanted into the mammary fat pads of
3-week-old mice from which the endogenous epithelium was
surgically removed. Most of the host fat pads (18 out of 22) were
successfully re-populated after 8 weeks, with the percentage of
mammary fat pad ﬁlled ranging from 5 to 100% (Fig. 1d).
To determine the functionality of the identiﬁed hormone
receptors at 30 days in culture, progesterone- and oestrogen-
free culture medium was supplemented with progesterone
(40 ngml 1) and/or oestrogen (4 ngml 1) for 4 or 24 h. These
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concentrations are in line with what is previously reported in
other culture systems in the literature11,26–29. The mRNA
expression of RankL, Wnt4, PR and ER was then analysed by
quantitative PCR. RANKL and Wnt4 have previously been
described as paracrine effectors of progesterone in vivo30. As
expected, a 4-h progesterone treatment signiﬁcantly increased
the expression of RankL and Wnt4 (Fig. 1e). Interestingly, RankL
expression was strongly reduced 4 h after oestrogen treatment,
remaining so at 24 h, and exhibited a similar pattern of regulation
to that of Wnt4 (Fig. 1e). Steroid hormone receptor expression is
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also known to be regulated by steroid hormone treatment31. As
such, 4 h of oestrogen and progesterone treatment signiﬁcantly
reduced ER and PR expression respectively. With the exception of
ER expression, the responses to hormone treatment at 24 h were
reduced by comparison with responses at 4 h. Co-treatment of
mammary organoids with both hormones had no signiﬁcant
effect on gene expression.
Using a trypsin-based dissociation approach, mammary
organoids were maintained for 2.5 months under these
conditions, retaining distinct cellular organization with functional
steroid hormone receptors and normal karyotype (Supplementary
Fig. 7). As previously described15,16,32, chromosomal spreads with
40±1 chromosomes were considered normal, due to the assay
limitations.
Taken together, these results suggest that Nrg1 may be a
critical regulator of mammary cells, that in vitro promotes the
development of mammary organoids with differentiated basal
and luminal cell compartments, functional steroid hormone
receptor-positive and -negative luminal cells and stem/progenitor
cells. Given this observation, we investigated whether Nrg1 has a
biological relevance in the mammary gland in vivo, by ﬁrst
determining the expression levels of the growth factor and its
receptors in different mammary epithelial cell populations.
Nrg1 and its receptors show reciprocal expression. To deﬁne
the expression pattern of Nrg1 and its receptors in the mammary
gland, mammary epithelial cell populations (luminal ERþ ,
luminal ER , myoepithelial and stem cell-enriched) from
10-week-old FvB mice were FACS sorted using the previously
described lineage markers CD24, Sca1 and CD49f (refs 33,34).
mRNA expression levels of Nrg1, Erbb3 and Erbb4 were
investigated by qRT-PCR (Fig. 2). Nrg1 and its receptors were
expressed in luminal CD24high Sca1þ (ERþ ) and CD24high
Sca1 (ER ) cell populations and in the basal myoepithelial
CD24low Sca1 CD49f low and stem cell-enriched CD24low
Sca1 CD49fhigh cell populations, but Erbb4 was not detected in
the CD24low Sca1 CD49fhigh population. Expression of Nrg1
was higher in basal cells than luminal cells, as recently descri-
bed35, while the Nrg1 receptors Erbb3 was expressed at higher
levels in luminal cells than in myoepithelial and stem
cell-enriched fractions. Erbb4 was expressed at higher levels in
CD24high Sca1 cells. This result suggests the potential for a
paracrine signalling network whereby basal cells secrete Nrg1,
which acts on luminal cells via Erbb3 and Erbb4 receptors.
Establishment of mammary cultures that resembleWnt1 tumours.
Wnt signalling plays a critical role in mammary gland develop-
ment, from regulating the elongation of the ductal tree-like
structure to pregnancy-induced lobulo-alveolar development36.
Due to similarities in Wnt signalling requirements for stem
cell function in the small intestine and mammary gland, the
growth factors that are required to maintain intestinal organoids,
namely EGF, Noggin and R-spondin 1 (Rspo), were tested in
our system13. In intestinal stem cells, Rspo potentiates Wnt
signalling, functioning as a ligand for leucine-rich repeat
containing G-protein-coupled receptor 5 (Lgr5), which forms a
complex with Wnt coreceptors37.
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Figure 2 | Nrg1 and ErbB are expressed in distinct mammary cell populations. Mammary epithelial cell populations were FACS sorted using a panel of
antibodies: CD24low Sca-1 CD49fhigh (stem cell-enriched fraction), CD24low Sca-1 CD49flow (myoepithelial cell population), CD24high
Sca-1 (luminal ER-negative cells) and CD24high Sca-1þ (luminal ER-positive cells). Expression of Neuregulin 1, Erbb3 and Erbb4 was evaluated by
quantitative RT-PCR (n¼ 3 independent experiments). Fold expression±95% conﬁdence over the comparator population (CD24highSca1 ). ND, no
expression of Erbb4 detected. *Po0.05; #0.05oPo0.1 (versus CD24high Sca1 ), unpaired Student’s t-test.
Figure 1 | Nrg1 mediates the extended growth of mammary organoids that retain a bilayered organization and response to steroid hormones.
(a) Mammary epithelial cells were embedded in growth-factor reduced matrigel and cultured in basal culture medium supplemented with Noggin
(100 ngml 1) and Nrg1 (100 ngml 1; n¼ 5). After 30 days in culture, organoids were ﬁxed, embedded in parafﬁn and sectioned. Sections were stained for
hematoxylin and eosin (H&E), basal markers: K14, p63, SMA; luminal markers: K8, PR; cell-proliferation markers: Ki-67 and BrdU; and cell organization
markers: b-catenin and NKCC1. Scale bars, 50mm, except for bright ﬁeld, b-catenin and BrdU, 25mm. Mammary organoids established from Axin2-LacZ
(Wnt reporter) mammary glands were ﬁxed and stained for b-galactosidase. (b) Detection of ER (green) and PR (red) in mammary organoid section
(n¼ 5). Counterstain, DAPI (blue). Scale bar, 50mm. (c) Mammary cells were exposed to increasing concentrations of Nrg1. After 30 days in culture, the
number of viable cells (Wst assay) was measured (n¼ 3, means±s.e.m.). (d) Representative picture of mammary gland successfully ﬁlled with a ductal
tree. Fifty mammary structures cultured for 30 days were transplanted into mammary fat pads of 3-week-old Rag-1 or FvB mice from which the endogenous
epithelium was surgically removed. In all, 18 out of 22 mammary fat pads were re-populated with various degrees (from 5 to 100%). (e) Expression of ER,
PR, RankL and Wnt4 following treatment with progesterone (P, 40 ngml 1), oestrogen (E, 4 ngml 1) or both hormones. Mammary organoids cultured for
30 days were treated for 4 and 24 h. Gene expression was evaluated by quantitative RT-PCR. Data are expressed as fold change over untreated controls
(n¼ 3, means±s.e.m.). *Po0.05, paired Student’s t-test.
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Figure 3 | R-spondin 1 promotes the growth of mammary organoids that are enriched in basal cells. (a) Mammary epithelial cells (n¼ 5) were
embedded in growth-factor reduced matrigel. After polymerization of matrigel, basal culture medium supplemented with R-spondin 1 (600ngml 1),
Noggin (100ngml 1) and EGF (50ngml 1) was overlaid. After 18 days in culture, organoids were ﬁxed, embedded in parafﬁn and sectioned. Sections
were stained for hematoxylin and eosin (H&E), basal markers: K14, p63, SMA; luminal markers: K8, progesterone receptor (PR); cell-proliferation markers:
Ki-67 and BrdU; and cell organization markers: b-catenin and NKCC1. Scale bars, 50mm, 30 mm (BrdU) and 25 mm (Ki-67). Mammary organoids
established from Axin2-LacZ (Wnt reporter) mammary glands were ﬁxed and stained for b-galactosidase. (b) Confocal images of organoids stained for p63
(green) and K14 (red; n¼ 5). Scale bar, 50mm. (c) Representative picture of metaphase chromosome spread that shows a normal number of chromosomes.
(d) Mammary cells were exposed to increasing concentrations of R-spondin 1. After 18 days in culture, cell viability (Wst assay) and the number of
structures were evaluated (n¼ 3, means±s.e.m.). (e) Representative picture of mammary gland successfully ﬁlled with a ductal tree. Mammary structures
cultured for 30 days were transplanted into mammary fat pads of 3-week-old FvB mice from which the endogenous epithelium was surgically removed.
In all, 9 out of 9 mammary fat pads were re-populated with various degrees (from 5 to 100%). *Po0.05, paired Student’s t-test.
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Mammary epithelial organoids were isolated and embedded as
previously described, and overlaid with basal culture medium
supplemented with Rspo (600 ngml 1), Noggin (100 ngml 1)
and EGF (50 ngml 1). After 18 days in culture under these
conditions, mammary epithelial organoids predominantly form
large oval or round structures (150–300 mm) that organize around
a central lumen (Fig. 3a). The epithelial cells express basal cell
markers, including p63 and K14, but the expression of SMA and
the luminal markers K8 and PR was undetectable (Fig. 3a,b).
Activation of Wnt signalling driven by Rspo here resembled the
formation of basal-enriched organoids previously reported
following inhibition of Notch signalling in mammary cell
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culture38. The epithelial cells, comprising a p63þ K14þ basal-
like population, were actively proliferating (Ki-67þ and BrdUþ )
and the majority of cells were Wnt responsive (Axin2-LacZþ ;
Fig. 3a). However, the nuclear accumulation of b-catenin,
a marker of Wnt signalling activation, was not observed, with
its localization instead detected at cell junctions (Supplementary
Fig. 3b). The cultured mammary cells expressed NKCC1 (Fig. 3a),
suggesting a ductal epithelial status of the cells in culture. This
phenotype was maintained to 30 days in culture, while the
karyotype at this point was essentially normal (71% of analysed
cells contained 40±1 chromosomes, n¼ 7; Fig. 3c).
Cell viability and the proportion of mammary cells and
structures was also dependent on the absolute levels of Rspo.
In the absence of Rspo, only small spherical structures that could
not be maintained for long term in culture were observed (Fig. 3d
and Supplementary Fig. 8a). Low Rspo levels maintained slow
organoid growth while high concentrations supported strong cell
proliferation and formation of basal-like structures (Fig. 3d and
Supplementary Fig. 8a). The activation of Wnt signalling in this
system was largely Rspo dependent, as removal of Rspo markedly
reduced the number of Axin2-LacZ-positive mammary structures
(Supplementary Fig. 8b,c).
The core of these non-transformed mammary structures
resembled typical squamous metaplasia observed in mammary
tumour tissues39, including MMTV-Wnt1-driven mammary
tumours that express K14 and p63 basal markers
(Supplementary Fig. 9).
To assess the regenerative potential of these organoids at
30 days in culture, ﬁfty basal cell-enriched organoids were
transplanted into cleared mammary fat pads of 3-week-old mice,
and all host mammary fat pads (9/9) were successfully ﬁlled
with a complete ductal tree after 8 weeks (Fig. 3e). Using a
trypsin-based dissociation approach, these mammary organoids
and their associated phenotype were maintained in culture long-
term (3.5–5 months), but exhibited an increase in chromosomal
number by this point (Supplementary Figs 10 and 11).
Taken together, the Rspo supplementation studies suggest
that Wnt pathway activity may promote organoid viability at
low levels, while driving basal differentiation that recapitulates
Wnt1-driven oncogenesis in vivo at high levels.
Nrg1 and Rspo support mammary organoid development in vitro.
Having established independently the importance of Nrg1 and
Wnt activation in promoting mammary organoid culture, in an
effort to maintain both luminal and basal cell compartments
in vitro the Nrg1 culture medium was supplemented with a low
concentration of Rspo (100 ngml 1).
After 30 days in culture, mammary organoids formed lobular
structures containing multiple lumens per lobule (Fig. 4a). In
contrast to Nrg1-only conditions, Axin2-LacZ positivity was
more strongly detected, and located at the edge of the mammary
structures where the K14þ /p63þ /SMAþ basal layer resided
(Fig. 4a and Supplementary Figs 12 and 13a), in line with
observations in vivo where Wnt-responsive cells have been
demonstrated to be located in the basal layer of mature ducts6.
In addition, in accordance with these ﬁndings, treatment of fully
grown mammary organoids with 100 ngml 1 Rspo for 6 days
promoted the activation of Wnt signalling, as marked by
the presence of Axin2-LacZ-positive cells at the edge of
mammary organoids (Supplementary Fig. 13b), although
nuclear accumulation of b-catenin was not observed
(Supplementary Fig. 3c). When compared with Nrg1-only
conditions, the basal cell layer was continuous, with no gaps
between basal cells observed (Fig. 4a,b and Supplementary
Fig. 12b). Crucially, in contrast to organoids grown under EGF,
Rspo-high conditions, structures under Nrg1, Rspo-low did not
show any hyperkeratinisation. At 30 days, these mammary
organoids were karyotypically normal (Fig. 4c and Supplementary
Fig. 12a). Cell numbers as assessed by mitochondrial activity were
increased by 50% following the addition of Rspo and Nrg1
(Fig. 4d). Time lapse imaging over 4 days suggested that this was
due to increased organoid size (Supplementary Movies 1 and 2).
Mammary structures grown in Nrg1-Rspo exhibited
differentiation and maintenance of a K8-positive luminal cell
population co-expressing ER and PR (Fig. 4a and Supplementary
Fig. 12) for at least 30 days in culture. Importantly, following
treatment with EdU 2 h before ﬁxation, co-immunoﬂuorescence
analysis revealed that PR-positive cells were distinct from
EdU-positive proliferating cells (Supplementary Fig. 14), as
observed in the normal mature duct in vivo40. Organized basal
and luminal compartments were clearly distinguishable,
as p63-positive cells and PR-positive cells were not co-localized
(Fig. 4b). Early time points were also assessed, highlighting this
speciﬁc cellular organization to already be present in culture at
day 3.5 and maintained at days 7 and 14 (Supplementary Fig. 15).
Within the basal compartment, rare p63-positive SMA-negative
cells were detected, corroborating observations in vivo where a
small number of K14þ /SMA- cells were identiﬁed within sorted
basal myoepithelial populations34 (Supplementary Fig. 12, white
arrows), although the function of this rare population remains
unclear. NKCC1 and b-catenin was localized at the cell
membrane of both basal and luminal cells at 30 days in culture
(Fig. 4a). Notably, Nrg1 was an absolute requirement as low-dose
Rspo treatment alone failed to generate mammary structures
(Supplementary Fig. 16).
Nrg1/Rspo-dependent organoids successfully re-populated
cleared mammary fat pads (6 out of 9 fat pads) on transplantation
(Fig. 4e). Furthermore, as observed in Nrg1-only culture
conditions, oestrogen and progesterone had opposing effects on
RankL gene-expression levels in organoids grown under these
Figure 4 | Nrg1 and R-spondin 1 enhance the formation of a basal cell layer while maintaining the luminal compartment. (a) Mammary epithelial cells
were embedded in growth-factor reduced matrigel. After polymerization of matrigel, basal culture medium supplemented with Noggin (100 ngml 1),
R-spondin 1 (100 ngml 1) and Nrg1 (100 ngml 1) was overlaid. After 30 days in culture, organoids were ﬁxed, embedded in parafﬁn and sectioned
(n¼ 5). Sections were stained for hematoxylin and eosin (H&E), basal markers: K14, p63, SMA; luminal markers: K8, PR; cell-proliferation markers: Ki-67
and BrdU; and cell-organization markers: b-catenin and NKCC1. Scale bars, 50mm except for bright ﬁeld, H&E, K8, Ki-67, BrdU and NKCC1 (25 mm).
Mammary organoids established from Axin2-LacZ (Wnt reporter) mammary glands were ﬁxed and stained for b-galactosidase. (b) Detection of p63
(green) and PR (red) in mammary organoid section. Counterstain, DAPI (blue; n¼ 5). Scale bar, 50mm. (c) Representative picture of metaphase
chromosome spread that shows a normal number of chromosomes. (d) Mammary cells were treated with Nrg1 (100ngml 1) or Nrg1þR-spondin 1
(100 ngml 1 each) for 30 days. The number of viable cells (Wst assay) was evaluated (n¼ 3, means±s.e.m.). (e) Representative picture of mammary
gland successfully ﬁlled with a ductal tree. Mammary structures cultured for 30 days were transplanted into mammary fat pads of 3-week-old FvB mice
from which the endogenous epithelium was surgically removed. In all, 6 out of 9 mammary fat pads were re-populated with various degrees (from 15
to 100%). (f) Expression of ER, PR, RankL and Wnt4 following treatment with progesterone (P, 40 ngml 1), oestrogen (E, 4 ngml 1) or both hormones.
Mammary organoids cultured for 30 days were treated for 4 and 24 h and gene expression evaluated by quantitative RT-PCR. Data are expressed as fold
change (versus untreated, n¼ 3, means±s.e.m.). *Po0.05, paired Student’s t-test.
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conditions (Fig. 4f). Similarly, oestrogen has been reported to
result in depression of RankL mRNA in vivo41, and may therefore
inhibit progesterone-induced RankL expression. Mammary
organoids containing distinct luminal and basal compartments
were also successfully generated from C57BL/6 mammary cells
(Supplementary Fig. 17).
Using a trypsin-based dissociation approach, karyotypically
normal, functional mammary organoids and their associated
phenotype were able to be maintained in extended culture for
2.5 months (Fig. 5 and Supplementary Table 3). In addition,
over this period of time, the number of organoids was 100-fold
increased compared with day 0 (Fig. 6e). However, after 4 months
in culture, cells exhibited an increase in chromosomal number, an
alteration of cell architecture with loss of luminal cells and
increased proliferative capacities (Fig. 6), indicative of aberrant
changes in organoid cultures at this time point.
To further investigate the requirement of the mammary
organoids for Wnt activity, an inducible Tet-O-DN89b-catenin
mouse model was used42. This system allows doxycycline-
dependent expression of activated b-catenin. Organoids were
grown under Nrg1-only conditions, supplemented with either low
concentrations of Rspo, doxycycline or both in combination.
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Figure 5 | Organoids grown for 70 days under Nrg1/Rspo culture conditions retain normal phenotype and functional steroid receptors.
Mammary organoids were cultured with 2.6 ngml 1 R-spondin 1 (Peprotech), 100 ngml 1 Nrg1 and 100ngml 1 Noggin for 70 days (4 passages).
(a) Representative bright ﬁeld image of the organoids. Scale bar, 100 mm. (b) Organoids were ﬁxed and stained for luminal markers PR, K8 and ER,
basal markers K14, p63, and Ki-67 and b-catenin. Counterstain, hoechst (blue). Scale bars, 50mm. (c) Quantiﬁcation of chromosome number in mammary
organoids cultured for 70 days (n¼ 15). Chromosomal spreads with 40±1 chromosomes were considered normal. (d) Representative picture of
metaphase chromosome spread that shows a normal number of chromosomes. (e) Percentage of PR-positive cells per organoid at different time points
in culture (n¼ 3). (f) Expression of PR, RankL and Wnt4 following treatment with oestrogen (E, 4 ngml 1) or progesterone (P, 40 ngml 1) for 4 h.
The gene expression was evaluated by quantitative RT-PCR. Data are expressed as fold change (versus untreated, n¼ 3, means±s.e.m.). *Po0.05,
paired Student’s t-test.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms13207
8 NATURE COMMUNICATIONS | 7:13207 | DOI: 10.1038/ncomms13207 | www.nature.com/naturecommunications
Results conﬁrmed that a low level of Wnt signalling induced
‘normal’ organoid morphology, while constitutive b-catenin
expression induced a squamous-like organoid morphology
resembling MMTV-Wnt1 tumours (Supplementary Fig. 18).
Furthermore, inhibitors of the Wnt pathway (IWP-2; Wnt
secretion inhibitor and IWR-1; Tankyrase inhibitor) reduced
organoid growth and PR expression, suggesting that mammary
organoids and hormone receptor-positive luminal cells in
particular have a basic requirement for Wnt ligand activity
(Supplementary Figs 19–22). Similarly, to characterize the
requirement of the mammary organoids for Nrg1/ErbBs active
signalling, a shRNA-mediated knock down of ErbB3 and ErbB4
was applied. Freshly isolated mammary epithelial cells were
transduced with lentiviral vectors and the size of the resulting
transduced (GFPþ ) organoids was measured compared with that
of a scrambled control, after 10 days in culture. Results illustrated
a reduction in organoid area on knockdown of either receptor,
with ErbB4 knockdown in particular restricting organoid size
to only 60% of control (Po0.01; Supplementary Fig. 23).
In addition, organoids grown under Nrg1-Rspo conditions were
successfully used to demonstrate an additional growth-promoting
effect of hepatocyte growth factor (HGF) without altering
organoid marker expression (Supplementary Figs 24–26).
Luminal ER-negative cells provide all cell lineages in vitro. To
investigate the cell of origin of the mammary organoids, single
d
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Figure 6 | Long-term culture of mammary organoids with Nrg1 and R-spondin 1 promotes chromosomal abnormalities. Mammary epithelial cells were
freshly isolated, embedded in matrigel, exposed to culture medium containing Nrg1 (100 ngml 1), Noggin (100ngml 1) and R-spondin 1 (2.7 ngml 1),
and cultured for 112 days (passaged 10 times). (a) Representative bright-ﬁeld images of mammary organoids. Scale bar, 100mm. (b) Mammary organoids
were ﬁxed and stained for the basal markers SMA, p63 and K14, and luminal markers PR, K8 and ER (DAPI, blue). Scale bar, 50 mm. (c) Quantiﬁcation of
chromosome number in mammary organoids (n¼ 29). Chromosomal spreads with 40±1 chromosomes were considered normal. (d) Representative
picture of metaphase chromosome spread that shows an aberrant number of chromosomes. (e) Quantiﬁcation of organoid expansion over time.
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FACS-sorted mammary cells of 10-week-old virgin mice were
embedded in matrigel and overlaid with medium containing Nrg1
(100 ngml 1), Rspo (100 ngml 1) and the Rho Kinase inhibitor
Y-27632 (10 mM), previously demonstrated to improve cell
survival following cell sorting13. Mammary organoids arose
predominantly from the CD24high luminal sub-populations and
were rarely observed in the CD24low basal sub-population
(Fig. 7a). The colony-forming efﬁciency of CD24high Sca1
luminal cells was nearly 6 and 40 times higher than those of
CD24high Sca1þ luminal cells and CD24low Sca1 basal cells,
respectively (Fig. 7b). The mammary structures that formed from
the CD24high Sca1 luminal ER cell population contained
distinct luminal and basal cell compartments, as marked by the
presence of an outer layer of p63/K14/K5-positive cells and an
inner population of ER/PR/K8-positive cells (Fig. 7c and
Supplementary Fig. 27). Similar results were obtained for the
CD24high Sca1þ luminal ERþ cells (Fig. 7c). Due to the low
frequency of basal outgrowths, their in depth analysis was not
possible. Collectively, these results suggest that the luminal
population, predominantly the ER mammary epithelial cells,
contain progenitor cells that can, under the conditions deﬁned,
directly contribute to the formation of both luminal and basal
compartments, as we initially proposed43.
Discussion
Recent advances in 3D culture systems have enabled the
establishment of organoids from various tissues that are
remarkably similar in organization and structure to the organs
that they are derived from4. Here, we describe the ﬁrst deﬁned
in vitro culture system that robustly recapitulates the murine
mammary duct differentiation found in situ and allows the
extended maintenance of normal primary mammary epithelial
cells. Rspo/Nrg1-dependent mammary organoids contain distinct
basal and luminal cell compartments, the latter comprising of
both ERþ and ER subtypes and progenitor cells that enable
organoid expansion for multiple passages over the course of 2.5
months, a signiﬁcant advancement over previously described
mammary culture conditions5,8–12. Crucially, the utility of the
system is further enhanced by the maintenance of hormone
responsive cells that retain functional steroid receptors capable of
regulating known downstream target genes, such as RankL and
Wnt4. Furthermore, the organized 3D structures grown here also
have full regenerative potential as demonstrated by their ability to
successfully recreate a complete mammary ductal tree in vivo.
Moreover, organoids can be genetically manipulated in culture
for further study or transplantation. Altogether, the data suggest
that this in vitro 3D culture system can serve as an instrumental
tool for investigating mammary gland biology, in addition for
potential drug-screening applications, as demonstrated here using
Wnt signalling inhibitors and HGF supplementation.
The reproductive history and lifetime hormone exposure of a
woman is intimately linked to her breast cancer risk44. As such,
a further understanding of normal mammary gland development,
in particular the molecular mechanisms of hormone action, is
critical for identifying the events that can lead to breast
tumourigenesis. Steroid hormones have been reported to
expand mammary stem cells in vivo, although the precise
factors that contribute towards maintaining the stem cell niche
remain poorly deﬁned30,45. Although a recent study has
demonstrated maintenance of PR expression in culture over
14 days10, most previous culture systems have failed to maintain
long-term expression of ER and PR in 3D cultures of normal
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mammary epithelium, leaving the investigation of mechanisms
of hormonal regulation to be principally driven by the use of ER/
PRþ breast cancer cell lines in vitro. As such, the mammary 3D
organoid culture method described provides an excellent system
in which to study such regulation of normal mammary epithelial
cells. Notably, a recent study utilizing a highly similar matrigel-
based 3D in vitro system demonstrated that single luminal
epithelial progenitors can generate prostate organoids in culture,
and that these also retained functional hormone (androgen)
receptor expression and downstream signalling46.
The Wnt signalling pathway is an important regulator of ductal
and lobulo-alveolar development and contributes to the self-
renewal and maintenance of basal cells, including mammary stem
cells6,36. The Wnt signalling potentiator Rspo has been implicated
in many in vitro systems that maintain and expand adult tissue
stem cells, including the intestine13, stomach14 and liver15. The
presence of Rspo was required in our (Neu/Rspo-low) culture
system, to support the growth and differentiation of the basal cell
layer. Interestingly, a recent study showed that mammary luminal
ER/PR-negative cells selectively secrete Rspo, while Wnt4 is
predominantly expressed in ER/PR-positive cells47, suggesting a
model for the hormonal regulation of basal mammary stem cells,
whereby these two luminal cell types provide the niche (Fig. 8).
In further support of this, the induction of Wnt4 by progesterone
in luminal ER/PR-positive cells has been suggested to drive
lobular development in pregnancy via its effects on basal stem
cells47. However, our studies argue that the highest Rspo levels
induce the development of undifferentiated and basal-only
structures, together with squamous metaplasia, as characteristic
of MMTV-Wnt1-driven mammary tumours in vivo. This
interesting observation suggests that a ‘just right’ level of Wnt
signalling may be necessary for normal mammary development
in which differentiated luminal and basal cells are present within
the same structures48, in contrast to other tissues (for example,
the intestine), which require high levels of R-spondin 1 for long-
term 3D in vitro culture. The requirement for basal-to-luminal
Nrg1/ErbB4 signalling in pregnancy has also been recently
reported35. Nrg1, which is reportedly secreted by basal
cells, directly regulates ErbB4-positive luminal progenitors
and promotes their proliferation and differentiation35.
The work presented here supports and reﬁnes this analysis by
demonstrating that cells that respond to Nrg1 are more likely to
reside in the population of luminal ER cells that express high
levels of the ErbB3 and ErbB4 Nrg1 receptors (Fig. 8).
Importantly, we observed that CD24high Sca1 luminal ER
cells generate mammary organoids containing distinct epithelial
compartments, suggesting that these cells can contribute to both
luminal and basal cell lineages in vitro, and highlighting their
potential high plasticity. While this ﬁnding contrasts with the
current model of mammary cell hierarchy whereby luminal
progenitors remain committed to the luminal lineage in vivo1,2, in
the context of transplantation, it is not uncommon for luminal
ER progenitor cells to generate both basal and luminal cell
lineages29,49, implying that transdifferentiation of these cells may
be possible in unusual physiological settings. Indeed, luminal-to-
basal reversion has been documented in breast cancer where
luminal tumour cells can acquire basal identity during invasion50.
Mammary epithelial cells expanded and maintained for
2.5 months under the described culture conditions retain normal
cellular architecture and growth potential, and crucially, using
karyotype analysis previously implemented in multiple published
organoid culture studies15,16,32, a normal (39–41) chromosome
count was observed after this period in culture. Intriguingly,
unlike comparable in vitro systems for the intestine that can
maintain karyotypically normal cells in culture for over a year13,
we observed that mammary organoids acquired chromosomal
abnormalities after 4 months. Whilst the intestine is required to
continually regenerate throughout life to maintain normal
physiological function, the inherent lifespan of the mammary
gland in contrast is relatively ﬁnite. In agreement with our
ﬁndings, Daniel and Young51 observed that growth senescence
was achieved on serial transplantation of mammary epithelial
cells, in a manner directly related to the number of cell divisions.
Our observation may therefore reﬂect the intrinsic biology of the
breast as compared with other tissues, and merits further
investigation in future studies.
By facilitating the simultaneous growth and maintenance of
multiple mammary epithelial cell types in culture, the in vitro
system described herein allows hormonal regulation and the
inter-cellular signalling between basal and luminal compartments
to be studied in an accessible, but normal mammary epithelial cell
environment. Furthermore, organoids are amenable to lentiviral
infection thus facilitating their genetic manipulation in culture, in
addition to possessing great potential as a drug-screening tool.
Finally, this system may facilitate the establishment of cancer
organoid culture conditions, given that tumour cells will have
arisen within a similar complex and heterogeneous environment.
Methods
Animal models and maintenance. All animal work was carried out under UK
Home Ofﬁce project and personal licences following local ethical approval and in
accordance with local and national guidelines.
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Figure 8 | Model of the Wnt/Nrg1 paracrine signalling network between
luminal and basal mammary epithelial cells. Basal cells secrete Nrg1,
resulting in Nrg1/ErbB signalling activation in luminal cells, promoting
luminal progenitor cell expansion and differentiation. In contrast,
progesterone-stimulated Wnt4 secretion by luminal ERþ cells, alongside
R-spondin 1 produced by luminal ER cells, activate Wnt signalling in the
basal stem/progenitor cell population via the Wnt receptors Fz and Lrp5/6
and the R-spondin 1 receptor Lgr5. Wnt signalling activation in this
compartment is likely to promote growth and differentiation of the
basal cell layer. Fz, frizzled; Lgr5, leucine-rich repeat-containing
G-protein-coupled receptor 5; Lrp5/6, low-density lipoprotein
receptor-related protein 5/6.
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Adult Axin2-LacZ52, Tet-O-DN89b-catenin42, wild-type FvB and C57BL/6
female mice (8–16 weeks old) were used in the experiments. Animals were
maintained under a 12/12 light/dark cycle at a temperature of 20 C with free
access to food and water.
Mammary organoid culture. Mammary epithelial organoids were collected from
fourth mammary fat pads of 8–12-week-old virgin mice24. Brieﬂy, fat pads were
chopped three times with a McIlwain Tissue Chopper (Mickle Laboratory
Engineering Company, Surrey, UK) and the ﬁnely minced tissue was transferred to
a digestion mix consisting of serum-free Leibowitz L15 medium (Gibco) containing
3mgml 1 collagenase A (Sigma) and 1.5mgml 1 trypsin (Sigma). This was
incubated for 1 h at 37 C to liberate epithelial tissue fragments (‘organoids’).
Isolated organoids were mixed with 50 ml of Matrigel (BD Biosciences) and
seeded in 24-well plates. The basal culture medium contained phenol red free
DMEM/F-12 with penicillin/streptomycin, 10mM HEPES, Glutamax, N2 and B27.
Progesterone-free B27 and N2 reagents were developed based on the original
formulation from Brewer et al.17 and adapted from Chen et al.18 (Supplementary
Tables 1 and 2)17,18. The basal medium was supplemented with three different
growth factor cocktails: (i) Nrg1 (100 ngml 1, R&D) and Noggin (100 ngml 1,
Peprotech), or (ii) EGF (50 ngml 1, Sigma Aldrich), R-spondin 1 (600 ngml 1,
R&D, or 42.5 ngml 1 Peprotech) and Noggin (100 ngml 1, Peprotech),
or (iii) Nrg1 (100 ngml 1, R&D), R-spondin 1 (100 ngml 1, R&D or 2.656ng
ml 1 Peprotech) and Noggin (100 ngml 1, Peprotech). Lower concentrations of
recombinant R-spondin 1 from Peprotech were used compared with R-spondin 1
from R&D due to its superior activity. In all, 500 ml of supplemented basal culture
medium was added per well and organoids were maintained in a 37 C humidiﬁed
atmosphere under 5% CO2.
Mammary organoids were maintained in culture for several months by
passaging them every 2–3 weeks using both mechanical and enzymatic approaches
(1:2 or 1:3 split ratio approximately). Brieﬂy, mammary organoids were released
from the matrigel by breaking the matrix with a P1000 pipette and were treated
with trypsin-EDTA 0.05% for 5min at 37 C. Following incubation with trypsin
inhibitor for 2min, mammary cells were strained through a 70 mm cell strainer
(BD Biosciences) on ice and centrifugated at 1,500 r.p.m. for 5min at 4 C.
Mammary cells were then resuspended in matrigel (50,000 cells per 50 ml), seeded
in 24-well plates and exposed to previously described culture conditions.
Mammary organoid cryopreservation. Organoids were grown for 3–4 days to
allow small structures to establish, before removal from Matrigel via washing
in cold DMEM/F-12 (up to a maximum of 6 wells per 12ml media), and
centrifugation at 1,500 r.p.m. for 5min. Organoids were then resuspended in
freezing media (50% DMEM/F-12, 40% FBS, 10% DMSO) at a density equivalent
to 1 wellml 1, and aliquoted at 1ml per cryovial. Cryovials were stored at
 80 C. For thawing, vials were placed in a 37 C waterbath and the contents
washed twice in DMEM/F-12, before reseeding in Matrigel at required density.
Thawed organoids were plated for the ﬁrst 5 days with media supplemented with
Y-27632 (10 mM).
Flow cytometry and cell sorting. Mammary epithelial organoids were collected
from fourth mammary fat pads of 10-week-old virgin mice as described above and
processed to single cells. Brieﬂy, isolated epithelial fragments were resuspended in
serum-free Joklik’s Modiﬁcation of Minimal Essential Medium for Suspension
Culture and incubated in a water bath at 37 C for 15min. Fragments were digested
to single cell using Trypsin-EDTA 0.05% (Invitrogen) for 2min at 37 C,
encouraged by gentle trituration by pipette. The suspension was the incubated with
5 mgml 1 DNase I in serum-free L-15 medium for 5min on ice, before addition of
20ml L-15/10% FBS-PSG. Single cells were strained through a 40 mm cell strainer,
pelleted at 250 g for 5min, and suspended in fresh L-15/10% FBS-PSG, counted
and plated at the desired density.
For ﬂow cytometry and sorting, mammary cell suspensions (106 cellsml 1)
were stained with anti-CD24-FITC (clone M1/69, BD Biosciences, Oxford, UK;
0.5 mgml 1.), anti-CD45-PE-Cy7 (clone 30-F11, BD Biosciences; 0.25 mgml 1),
anti-CD49f-PE-Cy5 (clone GoH3, BD Biosciences; 5.0 ml ml 1) and anti-Sca-1-PE
(clone D7, BD Biosciences, 0.5 mgml 1) (ref. 34). Cells were sorted at low pressure
(20 psi using a 100 mm nozzle) on a FACSAria (Becton Dickenson, UK) equipped
with violet (404 nm), blue (488 nm), green (532 nm), yellow (561 nm) and red
(635 nm) lasers. Both cell sample and collection tubes were maintained at 4 C.
Single stained samples were used as compensation controls. Dead cells, CD45þ
leucocytes and non-single cells were excluded. Within the CD24-positive
population, two separate cell populations were annotated as CD24High and
CD24Low (ref. 53). To standardize gating on CD49fHigh mammary epithelial cells,
we used 5% interval linear density contour plots and considered the outer edge of
the main body of the CD24Low cells, as deﬁned by the contour plots, to be the limit
above which cells can be considered CD49fHigh (ref. 33).
Single-cell mammary organoid culture. Freshly sorted cell populations were
plated on NuncTM MicroWellTM 96-Well Optical-Bottom plates in Matrigel
(9,500 cells per 9.5 ml) and overlaid with deﬁned basal culture medium,
supplemented with Nrg1 (100 ngml 1), Noggin (100 ngml 1) and R-Spondin 1
(2.6 ngml 1; Peprotech). Lower concentrations of recombinant R-spondin 1 from
Peprotech were used compared with R-spondin 1 from R&D (100 ngml 1) due to
its superior activity. Cultures were additionally treated with Rho kinase inhibitor
(Y-27632, 10mM, Tocris) for the ﬁrst 5 days. As previously observed for other
cell types13,54, Y-27632 in our hands increased the colony-forming efﬁciency of
single cells.
Whole-culture immunoﬂuorescence analysis. Whole-culture immuno-
ﬂuorescence was performed following ﬁxing of mammary organoids at stated time
points, by application of 4% paraformaldehyde at room temperature for 30min.
Each well was then washed with phosphate-buffered saline (PBS)-Glycine, three
times for 10min, and left overnight at 4 C in 10% horse serum (Invitrogen) diluted
in homemade immunoﬂuorescence buffer (Supplementary Table 4). Primary
antibodies, as detailed in Supplementary Table 5, were then applied diluted
in immunoﬂuorescence buffer overnight at 4 C. Following three washes in
immunoﬂuorescence buffer, secondary antibodies Alexa Fluor 488 goat anti-mouse
IgG (1/500, Invitrogen) and Alexa Fluor 568 goat anti-rabbit IgG (1/500,
Invitrogen) were applied overnight at 4 C. Following three washes in immuno-
ﬂuorescence buffer, Hoechst counterstain was applied for 30min, and samples
images in PBS. Confocal microscopy was performed using a Leica TCS SP2 AOBS
spectral confocal microscope, using the 20 objective. Images were then processed
using FIJI software.
Immunohistochemistry and immunoﬂuorescence. Mammary organoids in
matrigel were ﬁxed in 10% formalin, parafﬁn embedded and cut into 4 mm sections
for immunostaining. Brieﬂy, slides were boiled for 20min in antigen retrieval
solution (Dako) followed by blocking in 0.3% hydrogen peroxide for 5min and
goat serum for 45min (Vector). The antibodies, dilutions and incubation times
used in this study are listed in Supplementary Table 5. The speciﬁcity of antibodies
was validated on normal mammary gland tissue sections (Supplementary Fig. 5).
After 1-h incubation with biotinylated secondary antibody, detection was carried
out using a Vectastain ABC kit (Vector) for 30min and visualized with DAB
substrate chromogen for 10min (Sigma).
For immunoﬂuorescence, slides were treated as described above. Slides were
then exposed to Alexa Fluor 488 goat anti-mouse IgG (1/1,000, Invitrogen) and
Alexa Fluor 568 goat anti-rabbit IgG (1/1,000, Invitrogen) for 1 h and 40 ,
6-diamidino-2-phenylindole dihydrochloride (DAPI) stained (1/5,000).
Fluorescent images were taken on an IX-71 inverted microscope (Olympus,
Essex, UK) via an ORCA-ER camera utilizing SimplePCI software (Hamamatsu
Corporation, Hertfordshire, UK). Illumination intensity, exposure, offset and gain
settings were maintained between samples. Images were processed using FIJI
software.
Time lapse video-microscopy. Time lapse video-microscopy of mammary
organoid growth was carried out using an IX70 inverted DIC microscope
(Olympus) at 10 magniﬁcation and recorded using an ORCA-ER CCD camera
utilizing SimplePCI v6.0 software (Digitalpixal). Cells were maintained in a tem-
perature-controlled (37 C), humidiﬁed environment in the presence of 5% CO2
during imaging.
b-Galactosidase staining and cell viability. Mammary epithelial organoids were
isolated from fourth mammary fat pads of 8–12-week-old virgin Axin2-LacZ mice
and cultured under the three different conditions previously described. Wells were
washed in PBS, before application of LacZ ﬁxation solution (1:1 mix PBS:buffered
formalin (10%) with 4 ml ml 1 25% glutaraldehyde (1% ﬁnal)) for 1 h at RT. Wells
were then washed with PBS twice, and incubated overnight at RT in X-gal staining
solution (2.1mM MgCl2, 3mM K3Fe, 3mM K4Fe in PBS, with additional 4 ml per
ml 5% (w/v) X-gal in dimethylformamide supplemented). Wells were then washed
in PBS and ﬁnally ﬁxed in 10% buffered formalin to stop staining, before storage
in PBS.
Cell viability was measured using the cell-proliferation reagent WST-1 (Roche).
Brieﬂy, mammary organoids in matrigel were incubated with WST-1 reagent for
2 h at 37 C. The WST-1 solution was then transferred to a 96-well plate and
absorbance was measured at 450 nm using a BMG FLUOstar OPTIMA microplate
reader.
Karyotyping. Organoids grown under deﬁned conditions were treated with
0.05 mgml 1 Colcemid (Gibco, Invitrogen) for 16 h to arrest cells in metaphase.
Organoids were then washed and trypsinised as standard, before 15min treatment
with a hypotonic solution of potassium chloride (56mM). Single cells were
centrifugated at 1,200 r.p.m. for 4min and ﬁxed in 3:1 MeOH:Acetic acid by slow
addition over vortex. Cells were washed two further times in ﬁxative solution,
before plating onto slides to create chromosome spreads. Slides were aged
overnight at 55 C, before staining of chromosomes with DAPI. Images were
obtained using an Olympus IX73 40 microscope, with a 40 objective.
Chromosome spreads were counted manually using the ROI manager plugin of
ImageJ software. Compliant with previous publications in which organoid-derived
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cells have been karyotyped15,16,32, a normal karyotype was deﬁned as 39–41
chromosomes.
Mutant b-catenin induction in Tet-ODN89-b-Catenin organoids. Epithelial cells
were obtained as described above, from a tetracycline-inducible transgenic mouse
line, expressing a constitutively active, truncated b-catenin (DN89b-catenin)42.
Mice were untreated before dissection and experiment start point. Single cells were
plated at 1,000 per ml growth-factor reduced Matrigel, and overlaid with media
containing either Nrg1 (100 ngml 1) and Noggin (100 ngml 1) alone as a
negative control, or supplemented with R-Spondin 1 (2.656 ngml 1), Doxycycline
(2mgml 1) or both in combination. Measurements of organoid number and size
were taken at day 7.
Wnt signalling inhibitor assays. Freshly isolated mammary epithelial cells were
seeded in growth-factor reduced Matrigel at 1,000 cells per ml, and overlaid with
media containing Nrg1 (100 ngml 1), Noggin (100 ngml 1), R-Spondin 1
(2.656 ngml 1) and a ﬁxed concentration of either IWP-2 (Sigma Aldrich; 0.5, 1, 2
or 4 mM) or IWR-1 (Sigma Aldrich; 37.5, 75, 150 or 300 nM), for 14 days in culture.
Organoid number and diameter for each titration was then analysed using
GelCountTM software and compared with a DMSO-matched control.
Lentiviral knockdown of ErbB3/ErbB4. shRNAs were developed using the
Block-It shRNA system (Thermo Fisher) against both Erbb3 and Erbb4 cloned into
a Gateway modiﬁed pSEW vector (Groner Lab). Lentiviral pseudo-virus was
produced using the psPAX2 and PMD.G2 lentiviral packaging plasmids (Trono
lab). Lentiviral titre was established and test cells were infected at an MOI of 43.
For infection, freshly isolated single mammary epithelial cells were resuspended
in an equal mix of Matrigel and lentiviral suspension, and plated over a pre-set thin
layer of 100% Matrigel in 48-well plates. Each well was then overlaid with culture
media containing Nrg1 (100 ngml 1), Noggin (100 ngml 1) and R-Spondin 1
(2.656 ngml 1). After 24 h to allow cells to settle into the Matrigel and infection to
occur, media was replaced. This process was repeated every 2 days.
Plates were ﬁxed after 10 days and counterstained with DAPI, and images taken
with Olympus IX73 microscope, with a 10 objective. Organoid number and size
was analysed using ImageJ.
HGF addition assays. Freshly isolated mammary epithelial cells were seeded in
growth-factor reduced Matrigel at 1,000 cells per ml, and overlaid with media
containing Nrg1 (100 ngml 1), Noggin (100 ngml 1), R-Spondin 1
(2.656 ngml 1) and a ﬁxed concentration of HGF (Peprotech; 3.125, 6.25, 12.5, 25
or 50 ngml 1). At 11 days in culture, organoid number and diameter per well was
then analysed using GelCountTM software and compared with an untreated
control.
Cleared mammary fat pad transplantation. Mammary organoids were cultured
for 30 days under the 3 different culture conditions described. In all, 50 organoids
were transplanted per mammary fat pad of 3-week-old Rag-1 or FvB mice from
which the endogenous epithelium was surgically removed53. Eight weeks after
transplantation, fat pads were whole-mounted, stained with carmine and analysed.
Failed clears were excluded from the analysis. Wholemounts were examined on a
binocular microscope (Zeiss, Stemi SV11). Images were captured with a Canon
PC1089 camera and Canon Zoom Browser software (with white balance set to
ﬂuorescent and auto exposure activated).
RNA isolation and qPCR. Freshly sorted normal cell populations were resus-
pended in RLT buffer. Total RNA was isolated using RNeasy Mini kit (Qiagen)
following the manufacturer’s recommendations. DNA was eliminated using gDNA
spin columns during RNA isolation and gDNA Wipeout Buffer during cDNA
retrotranscription. cDNA synthesis was performed using QuantiTect Reverse
Transcription Kit (Qiagen). Quantitative real-time PCR was carried out using the
following TaqMan assays: Mm00695835_m1 (Erbb3), Mm01256814_m1 (Erbb4)
and Mm00626552_m1 (Nrg1). Gene assays were done on triplicates. Three
experimental replicates were done using different animal sets.
For in vitro experiments, mammary organoids cultured for 30 days were treated
with oestrogen (4 ngml 1; Sigma Aldrich), progesterone (40 ngml 1; Sigma
Aldrich) or both for 4 or 24 h in phenol red free conditions. Matrigel was
mechanically dissociated and organoids were pelleted by centrifugation at
1,000 r.p.m. for 3min. RNA was extracted using the RNeasy micro kit (Qiagen). In
all, 1 mg of total RNA was reverse transcribed using random hexamers (Promega)
and Superscript III reverse transcriptase (Invitrogen). The qRT-PCR was
performed using FastSybr Green Master Mix kit (Applied Biosystems). Duplicate
samples were analysed on a StepOnePlus (Applied Biosystems) qRT-PCR machine
using the fast protocol. b-2 microglobulin, ribosomal protein L13A (RPL13A) and
hypoxanthine phosphoribosyltransferase were selected as normalizers. Threshold
cycle (CT) values and the 2-DDCT method were used to calculate expression
changes. Supplementary Table 6 contains the list of primers used in this study.
Data availability. The data supporting the ﬁndings of this study are available
within the article and its Supplementary Information Files. All other relevant
source data are available from the authors on request.
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